The new brain center will focus on research translating genetic, metabolic and molecular insights into interventions that protect those at risk before brain changes set in. The medical community can foresee a looming increase in Alzheimer’s disease, the most common form of dementia, as the population ages. The number of Americans affected is projected to...
Tag: <span>New path</span>
Post
A new path for treating brain cancer, with a developed compound
Yale researchers have developed a new class of molecules targeting some deadliest brain cancers while sparing healthy tissue. The discovery, which combines innovative synthetic chemistry and cutting-edge mechanistic studies in molecular biology, offers a potentially powerful new approach to treating drug-resistant glioma tumors that form in the brain and spinal cord. A study describing the...
Post
New path to treat advanced triple-negative breast cancer
by Anne Doerr, Yale University Credit: Yale University A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative breast cancer (TNBC), one of the most difficult disease sub-types to treat....